￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Will long-term use of avatrombopag (Suxin) cause drug resistance?

2026-02-01 22:25:32

Check Details
Is the efficacy of avatrombopag (Sucoxin) absolute?

2026-02-01 22:25:32

Check Details
Overview of the efficacy and functions of avatrombopag (Sucoxin)

2026-02-01 22:25:32

Check Details
A brief description of the treatment cycle of avatrombopag (Sucoxin)

2026-02-01 22:25:32

Check Details
Overview of applicable patient groups and efficacy of avatrombopag (Sucoxin)

2026-02-01 22:25:32

Check Details
Dasatinib price and availability

2026-02-01 22:25:32

Check Details
Is dasatinib effective in treating chronic myelogenous leukemia?

2026-02-01 22:25:32

Check Details
Dasatinib adverse reactions

2026-02-01 22:25:32

Check Details
What is the difference between dasatinib and imatinib?

2026-02-01 22:25:32

Check Details
What should I avoid while taking dasatinib?

2026-02-01 22:25:32

Check Details
Three-year follow-up data of maintenance therapy with rucaparib/rucaparib in patients with ovarian cancer

2026-02-01 22:25:32

Check Details
Instructions for Rucapani/Rucapali

2026-02-01 22:25:32

Check Details
Category
相关知识